CLN5 Gene Ceroid lipofuscinosis neuronal type 5 Genetic Test
Components: CLN5 Gene Ceroid lipofuscinosis neuronal type 5 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CLN5 Gene Ceroid lipofuscinosis neuronal type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 5.
Test Details
The CLN5 gene is associated with a rare genetic disorder called ceroid lipofuscinosis neuronal type 5 (CLN5). This disorder is characterized by the accumulation of lipopigments in various tissues, including the brain, leading to progressive neurodegeneration.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses high-throughput sequencing technology to analyze multiple genes simultaneously. In the case of CLN5 gene testing, NGS can be used to identify mutations or variations in the CLN5 gene that may be responsible for the development of ceroid lipofuscinosis neuronal type 5.
NGS genetic testing for CLN5 gene mutations can be helpful in diagnosing individuals suspected of having CLN5-related ceroid lipofuscinosis. It can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families with a known CLN5 mutation.
By identifying specific mutations in the CLN5 gene, NGS genetic testing can provide valuable information for accurate diagnosis, genetic counseling, and potential treatment options for individuals and families affected by ceroid lipofuscinosis neuronal type 5.
| Test Name | CLN5 Gene Ceroid lipofuscinosis neuronal type 5 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CLN5 Gene Ceroid lipofuscinosis neuronal type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 5 |
| Test Details |
The CLN5 gene is associated with a rare genetic disorder called ceroid lipofuscinosis neuronal type 5 (CLN5). This disorder is characterized by the accumulation of lipopigments in various tissues, including the brain, leading to progressive neurodegeneration. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses high-throughput sequencing technology to analyze multiple genes simultaneously. In the case of CLN5 gene testing, NGS can be used to identify mutations or variations in the CLN5 gene that may be responsible for the development of ceroid lipofuscinosis neuronal type 5. NGS genetic testing for CLN5 gene mutations can be helpful in diagnosing individuals suspected of having CLN5-related ceroid lipofuscinosis. It can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families with a known CLN5 mutation. By identifying specific mutations in the CLN5 gene, NGS genetic testing can provide valuable information for accurate diagnosis, genetic counseling, and potential treatment options for individuals and families affected by ceroid lipofuscinosis neuronal type 5. |
